The changing natural history of renal cell carcinoma.
暂无分享,去创建一个
[1] P. Black,et al. Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long-term outcome in 180 patients. , 2000, Urology.
[2] É. Lechevallier,et al. A french national epidemiologic survey on renal cell carcinoma , 1998, Cancer.
[3] S. Libutti,et al. A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. , 2000, The Journal of urology.
[4] A W Partin,et al. Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinoma. , 1999, Urology.
[5] Sheue-yann Cheng,et al. New Insights into the Structure and Function of the Thyroid Hormone Receptor. , 1995 .
[6] B. Delahunt,et al. Nucleolar organizer regions and prognosis in renal cell carcinoma , 1991, The Journal of pathology.
[7] F. Marshall,et al. The national cancer data base , 1997, Cancer.
[8] A. Megibow,et al. Renal cell carcinoma: earlier discovery and increased detection. , 1989, Radiology.
[9] S. Rafla,et al. Renal cell carcinoma. Natural history and results of treatment , 1970, Cancer.
[10] R. Clayman,et al. Laparoscopic radical nephrectomy for renal tumor: the Washington University experience. , 1996, The Journal of urology.
[11] G. Farrow,et al. Sarcomatoid renal carcinoma. , 1983, The Journal of urology.
[12] R. Stanley,et al. Papillary renal cell carcinoma. A clinical, radiologic, and pathologic study of 34 cases , 1976, Cancer.
[13] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[14] N. Goldstein,et al. The current state of renal cell carcinoma grading , 1997, Cancer.
[15] J. Thrasher,et al. Prognostic factors in renal cancer. , 1993, The Urologic clinics of North America.
[16] R. Figlin,et al. Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience. , 1996, Seminars in urologic oncology.
[17] A. Novick,et al. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.
[18] Parkin Dm,et al. Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .
[19] D. Grignon,et al. Role of nuclear grading in stage I renal cell carcinoma. , 1989, Urology.
[20] P. Lipponen,et al. Prognostic value of Ki-67 expression in renal cell carcinomas. , 1997, European urology.
[21] W. Linehan,et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. , 2000, The New England journal of medicine.
[22] B. Delahunt,et al. Classification of renal cell carcinoma , 1997, Cancer.
[23] R. Figlin,et al. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. , 2000, The Journal of urology.
[24] P R Mueller,et al. Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. , 1999, The Journal of urology.
[25] D. Trump,et al. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. , 1988, Cancer research.
[26] Wirth Mp. Immunotherapy for metastatic renal cell carcinoma. , 1993 .
[27] G. Cevenini,et al. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival. , 1998, Pathology, research and practice.
[28] L. Schwartz,et al. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Robert G. Moore,et al. Laparoscopic nephrectomy for renal cell cancer: evaluation of efficacy and safety: a multicenter experience. , 1998, Urology.
[30] G. Farrow,et al. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults—part II , 1968 .
[31] R. Figlin,et al. The treatment of renal cell carcinoma with human leukocyte alpha-interferon. , 1983, The Journal of urology.
[32] R. Clayman,et al. Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] H. Moch,et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.
[34] R. Flocks,et al. [Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more]. , 1958, Transactions of the American Association of Genito-Urinary Surgeons.
[35] Robert B. Shibuya,et al. Stage I Renal Cell Carcinoma: A Clinicopathologic Study of 82 Cases , 1993, The American journal of surgical pathology.
[36] A. Novick,et al. Nephron sparing surgery in incidental versus suspected renal cell carcinoma. , 1994, The Journal of urology.
[37] B. Williams,et al. P53, bcl-2, and Bax expression in renal cell carcinoma. , 1998, Urology.
[38] J. Quesada,et al. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] J. Lloreta,et al. Cystic renal cell carcinoma: pathological features, survival and implications for treatment. , 1998, British journal of urology.
[40] A. Spouge,et al. Abdominal sonography in asymptomatic executives: prevalence of pathologic findings, potential benefits, and problems. , 1996, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[41] M. Atkins,et al. Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma. , 1997, The Journal of urology.
[42] A. Renshaw,et al. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. , 1997, The American journal of surgical pathology.
[43] K. Cummings,et al. National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening. , 1998, Urology.
[44] R. Smith,et al. Reexamining the value of hematuria testing in patients with acute flank pain. , 1999, The Journal of urology.
[45] T. Berge,et al. Clinically unrecognized renal cell carcinoma. Diagnostic and pathological aspects. , 1990, European urology.
[46] Y. Homma,et al. INCREASED INCIDENTAL DETECTION AND REDUCED MORTALITY IN RENAL CANCER—RECENT RETROSPECTIVE ANALYSIS AT EIGHT INSTITUTIONS , 1995, International journal of urology : official journal of the Japanese Urological Association.
[47] A. Gross,et al. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids , 2000, Nature Medicine.
[48] R. Cestari,et al. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). , 2000, Urology.
[49] H. Müller-Hermelink,et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma , 1995, Cancer.
[50] C. J. Robson. Radical nephrectomy for renal cell carcinoma. , 1963, The Journal of urology.
[51] J. Ro,et al. Sarcomatoid renal cell carcinoma: Clinicopathologic. A study of 42 cases , 1987, Cancer.
[52] A. Belldegrun,et al. Incidental renal tumors. , 2000, Urology.
[53] Christian Coulange,et al. Prognostic value of nuclear grade of renal cell carcinoma , 1995, Cancer.
[54] V. Onufrey,et al. Radiation therapy in the treatment of metastatic renal cell carcinoma. , 1985, International journal of radiation oncology, biology, physics.
[55] Novick Ac. Laparoscopic live donor nephrectomy: con. , 1999 .
[56] D. Johnson,et al. Is nephrectomy justified in patients with metastatic renal carcinoma? , 1975, The Journal of urology.
[57] K. Katz,et al. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. , 1995, The Journal of urology.
[58] J. Cohen,et al. Intraoperative ultrasonographically guided cryoablation of renal masses: initial experience. , 1998, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[59] P. Hermanek,et al. Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. , 1990, The Journal of urology.
[60] K. Aozasa,et al. Prognostic factors of renal cell carcinoma: A multivariate analysis , 1998, Journal of surgical oncology.
[61] E. T. Bell. A Classification of Renal Tumors with Observations on the Frequency of the Various Types1 , 1938 .
[62] M. Merino,et al. Collecting duct carcinoma of the kidney. , 1990, Human pathology.
[63] R. Figlin,et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. , 2001, The Journal of urology.
[64] J L Warren,et al. Rising incidence of renal cell cancer in the United States. , 1999, JAMA.
[65] I. Derweesh,et al. Nephron-sparing surgery for renal cell carcinoma. , 2003, Cancer treatment and research.
[66] D. Paulson,et al. Stratification of risk factors in renal cell carcinoma , 1983 .
[67] A. Bertuzzi,et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. , 1997, European urology.
[68] A. Gelb. Renal cell carcinoma , 1997 .
[69] B. Rini,et al. Prognostic factors in renal carcinoma. , 2000, Seminars in oncology.
[70] P. Gann. Interpreting recent trends in prostate cancer incidence and mortality. , 1997, Epidemiology.
[71] J. Xipell,et al. The incidence of benign renal nodules (a clinicopathologic study). , 1971, The Journal of urology.
[72] F. Mostofi,et al. Renal Medullary Carcinoma The Seventh Sickle Cell Nephropathy , 1995, The American journal of surgical pathology.
[73] L. Medeiros,et al. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases , 1988, Cancer.
[74] T. Sejima,et al. Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell Carcinoma , 1999, European Urology.
[75] C. Logothetis,et al. Sarcomatoid renal cell carcinoma. A treatable entity , 1987, Cancer.
[76] A. Novick,et al. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.
[77] H. Herr. Partial nephrectomy for incidental renal cell carcinoma. , 1994, British journal of urology.
[78] R. Figlin,et al. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. , 2000, The Journal of urology.
[79] R. Motzer,et al. Systemic therapy for renal cell carcinoma. , 2000, The Journal of urology.
[80] M. Ali,et al. Chromophobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases. , 1995 .
[81] D. Bostwick,et al. Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. , 1996, The Journal of urology.
[82] R. Bukowski. Natural history and therapy of metastatic renal cell carcinoma , 1997, Cancer.
[83] J. Portillo,et al. Nuclear morphometry in prognosis of renal adenocarcinoma. , 1992, Urology.
[84] M. Tillich,et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (< 3-cm) renal masses. , 1997, Radiology.
[85] R. B. Smith,et al. The natural history of metastatic renal cell carcinoma: a computer analysis. , 1978, The Journal of urology.
[86] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[87] Impact of tumor size on the clinical outcomes of patients with Robson Stage I renal cell carcinoma , 1999, Cancer.
[88] L. Sobin,et al. Union Internationale Contre le Cancer (UICC) and the American Joint TNM Staging of Renal Cell Committee on Cancer (AJCC) Carcinoma , 1997 .
[89] Max H. Myers,et al. Manual for Staging of Cancer , 1992 .
[90] M. Rubenstein,et al. Report of 337 patients with renal cell carcinoma emphasizing 110 with Stage IV disease and review of the literature , 1997, Journal of surgical oncology.
[91] D. Petrylak,et al. Cytotoxic chemotherapy for advanced renal cell carcinoma. , 1993, The Urologic clinics of North America.
[92] J. W. Segura,et al. Renal cell carcinoma: long-term survival and late recurrence. , 1981, The Journal of urology.
[93] R. Machinami,et al. Sarcomatoid renal cell carcinoma. A study of its proliferative activity , 1993, Cancer.
[94] R. Figlin,et al. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. , 1999, The Journal of urology.
[95] D. Skinner,et al. Renal carcinoma: computer analysis of 96 patients treated by nephrectomy. , 1979, The Journal of urology.
[96] R. Figlin,et al. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.
[97] M Mazumdar,et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] I. Thompson,et al. Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor. , 1988, The Journal of urology.
[99] M Jayson,et al. Increased incidence of serendipitously discovered renal cell carcinoma. , 1998, Urology.
[100] C. Dinney,et al. Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. , 1992, Urology.
[101] G. Prout,et al. Validation of the tumor, nodes and metastasis classification of renal cell carcinoma. , 1985, The Journal of urology.
[102] R. Colvin,et al. Diagnosis and management of renal cell carcinoma A clinical and pathologic study of 309 cases , 1971, Cancer.
[103] Onishi,et al. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients , 1999, BJU international.
[104] J. Thornhill,et al. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment. , 1996, British journal of urology.
[105] W. Taylor,et al. Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival. , 1988, The Journal of urology.
[106] S. Mihara,et al. Early detection of renal cell carcinoma by ultrasonographic screening--based on the results of 13 years screening in Japan. , 1999, Ultrasound in medicine & biology.
[107] R. Figlin,et al. Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[108] W. Thoenes,et al. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. , 1986, Pathology, research and practice.
[109] J. Cerny,et al. Aggressive versus conservative management of stage IV renal cell carcinoma. , 1977, The Journal of urology.
[110] H. Grossman,et al. Renal cell carcinoma as an incidental finding. , 1985, The Journal of urology.
[111] J. Cheville,et al. Grading of renal cell carcinoma , 1997, Cancer.
[112] R. Motzer,et al. Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[113] R. Fisher,et al. Interleukin-2-based therapy for metastatic renal cell cancer: the Cytokine Working Group experience, 1989-1997. , 1997, The cancer journal from Scientific American.
[114] S. Fleming,et al. Collecting duct carcinoma of the kidney , 1986, Histopathology.
[115] R. Figlin,et al. Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. , 1997, The Journal of urology.
[116] L. Baert,et al. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. , 1998, The Journal of urology.
[117] P. Russo,et al. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. , 2000, The Journal of urology.
[118] M. Menon,et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. , 1999, The Journal of urology.
[119] M. Nurmi. Prognostic factors in renal carcinoma. An evaluation of operative findings. , 1984, British journal of urology.
[120] M. Blute,et al. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. , 1999, The Journal of urology.
[121] M. Steiner,et al. Campbell's Urology, 7th ed. , 1998 .
[122] A. Renshaw,et al. Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. , 1999, American journal of clinical pathology.
[123] John R. Hand,et al. Carcinoma of the Kidney: The Degree of Malignancy in Relation to Factors Bearing on Prognosis1 , 1932 .
[124] Y. Mihara,et al. Incidental detection of renal carcinoma during radiological imaging. , 1987, British journal of urology.
[125] D. Grignon,et al. Renal cell carcinoma. A clinicopathologic and dna flow cytometric analysis of 103 cases , 1989, Cancer.
[126] B. Bochner,et al. The T pouch: an orthotopic ileal neobladder incorporating a serosal lined ileal antireflux technique. , 1998, The Journal of urology.
[127] R. Figlin,et al. Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] G. Farrow,et al. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. , 1995, The Journal of urology.
[129] L. Sobin,et al. TNM staging of renal cell carcinoma , 1997, Cancer.
[130] M. Stöckle,et al. Conservative surgery of renal cell tumors in 140 patients: 21 years of experience. , 1992, The Journal of urology.
[131] G. Weiss,et al. The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon. , 1998, The cancer journal from Scientific American.
[132] K. Nishimura,et al. Chromophobe Cell Renal Carcinoma , 1999, Urologia Internationalis.
[133] S. Al-Askari,et al. Renal cell carcinoma: survival and prognostic factors. , 1986, Urology.
[134] M. Rubenstein,et al. Staging and survival of patients with renal cell carcinoma. , 1994, Seminars in surgical oncology.
[135] F. Marshall,et al. Diagnosis of Renal Cancer by Molecular Urinalysis , 1999 .
[136] N. P. Patel,et al. Renal cell carcinoma: natural history and results of treatment. , 1978, The Journal of urology.
[137] A. Llombart‐Bosch,et al. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma. , 1998, Anticancer research.
[138] J. Ruiz,et al. Value of morphometry as an independent prognostic factor in renal cell carcinoma. , 1995, European urology.
[139] J. Dekernion,et al. Prognostic factors in metastatic renal carcinoma. , 1986, The Journal of urology.
[140] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.
[141] R. Figlin. Renal cell carcinoma: management of advanced disease. , 1999, The Journal of urology.